219
Participants
Start Date
February 12, 2016
Primary Completion Date
January 15, 2021
Study Completion Date
January 15, 2021
OSE2101
Docetaxel
Pemetrexed
IRCCS Regina Elena National Cancer Institute, Roma
Magyar Honvedseg Egeszsegugyi Kozpont II szamu telephely, Budapest
Országos Korányi TBC és Pulmonológiai Intézet XI Tüdőbelosztály, Budapest
Országos Korányi TBC és Pulmonológiai Intézet XIV Tüdőbelosztály, Budapest
Semmelweis Egyetem Altalanos Orvostudományi Kar Pulmonologiai Klinika, Budapest
Matrai Gyogyintézet, Mátraháza
Csongrad Megyei Mellkasi Betegsegek Szakkorháza I Tüdőosztály, Deszk
Centre Hospitalier Troyes, Troyes
Všeobecná Fakultní nemocnice, Prague
Paoli-Calmettes Institute, Marseille
"Complejo Hospitalario Universitario A Coruna (CHUAC)", A Coruña
Gesinger Medical Center, Danville
Georgetown University Hospital, Washington D.C.
Hospital Universitario La Paz Servicio de Oncología Médica, Madrid
Hospital Universitario Puerta de Hierro Majadahonda Servicio de Oncología Médica Consultas externas, 2ª planta, Madrid
Hospital Universitario Carlos Haya, Málaga
CHGU Morvan - Brest, Brest
Hôpital Larrey - CHU de Toulouse, Toulouse
Institut Bergonié, Bordeaux
BRCR Medical Center, Inc, Boca Raton
CHU Montpellier, Montpellier
Istituto Oncologico Veneto, IRCCS, Padua
Centre Hospitalier Régional Universitaire de Tours, Tours
Oncologia medica, Legnano
Ospedale Civile Maggiore, Verona
CHU Grenoble, Grenoble
Centre Catherine de Sienne, Nantes
Meir Medical Center, Kfar Saba
Gabrail Cancer Center Research, Canton
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T), Meldola
U.O. Oncologia Ospedale Infermi, Rimini
Centre Hospitalier de Cholet, Cholet
Krankenhaus Mehrheit - Kliniken der Stadt Köln - Lungenklinik, Cologne
Policlinico Santa Maria alle Scotte, Siena
Azienda USL 2 Lucca - Dipartimento Oncologico, Lucca
Nemocnice Jihlava, Onkologické oddelení, Jihlava
Hopital Albert Calmette, Lille
CHU de Strasbourg - Hôpital Civil, Strasbourg
Hôpital Emile Muller, Mulhouse
Hôpital Louis Pradel, Bron
IRCCS Oncologico Giovanni Paolo II, Bari
Pontchartrain Cancer Center, Covington
Clinique Victor Hugo, Le Mans
Centre Hospitalier du Mans, Le Mans
Universitätsklinikum Tübingen Medizinische Klinik II, Tübingen
Unità Operativa di Oncologia dell'Ospedale Vito Fazzi di Lecce, Piazza Muratore, Lecce
Stephenson Cancer Center, Oklahoma City
Hôpital Saint-Louis, Paris
Hôpital Bichat - Claude-Bernard, Paris
Hôpital Tenon, Paris
Millenium Oncology, Houston
U.O.C. Pneumologia a indirizzo oncologico, Presidio Ospedaliero Monaldi - Azienda Ospedaliera dei Colli - Via Leonardo Bianchi, Napoli
Soroka University Medical Center, Beersheba
Institut Saint Catherine, Avignon
Klinik für Innere Medizin II Universitätsklinikum Ulm, Ulm
East Valley Hematology and Oncology medical Group, Burbank
Hôpital Avicenne, Bobigny
Hôpital intercommunal de Créteil, Créteil
Hôpital d'Instruction des Armées Bégin, Saint-Mandé
Institut Gustave Roussy (IGR), Villejuif
Robert W. Franz Cancer Center, Portland
Meyer Cancer Center, Weill Cornell Medecine, New York
Rambam Health Care Campus, Haifa
Rabin (Belinson) Medical Center, Petah Tikva
Hadassah Campus Ein Kerem, Jerusalem
Klinik für Innere Medizin II Hospital Martha-Maria Halle-Dölau gGmbH, Halle
Ospedale di Perugia - Oncologia medica, Perugia
UOC di Oncologia Medica, Policlinico Universitario Campus Biomedico, Roma
Klinika Onkologii i Radioterapii , Uniwersyteckie Centrum Kliniczne, Gdansk
"Przychodnia Lekarska KOMED", Konin
Mazowieckie Centrum Leczenia chorób Płuc i Gruźlicy, Otwock
Wojewódzki Szpital Zespolony , Oddział Chemioterapii Nowotworów, Torun
Hospital Universitari Quirón Dexeus, Barcelona
Hospital Universitari Vall D'Hebron, Barcelona
Hospital de Mataro, Barcelona
Hospital de Mataro, Mataró
Hospital Universitario Germans Trias i Pujol, Barcelona
Milton Keynes Hospital, Milton Keynes
Lead Sponsor
OSE Immunotherapeutics
INDUSTRY